SSW
MEDP icon

Smith Shellnut Wilson’s Medpace MEDP Stock Holding History

Smith Shellnut Wilson’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$510K Hold
963
– – 0.19% 85
2026
Q1 		$462K Hold
963
– – 0.2% 81
2025
Q4 		$541K Hold
963
– – 0.21% 76
2025
Q3 		$495K Hold
963
– – 0.19% 75
2025
Q2 		$302K Hold
963
– – 0.13% 107
2025
Q1 		$293K Hold
963
– – 0.13% 110
2024
Q4 		$320K Hold
963
– – 0.14% 101
2024
Q3 		$321K Hold
963
– – 0.15% 104
2024
Q2 		$397K Buy
+963
New +$381K 0.19% 84

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Smith Shellnut Wilson's MEDP Position: Q2 2026 in Review

Smith Shellnut Wilson held its Medpace (MEDP) position steady in Q2 2026 at 963 shares worth $510K. The position accounts for 0.19% of the portfolio, ranked #85.

Smith Shellnut Wilson first reported a position in MEDP in Q2 2024 and has held it in 9 quarters since. The position peaked at $541K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Smith Shellnut Wilson held 963 shares of Medpace worth $510K as of Q2 2026.
  • Smith Shellnut Wilson left its Medpace share count unchanged in Q2 2026.
  • Medpace made up 0.19% of Smith Shellnut Wilson's portfolio in Q2 2026, its #85 holding.
  • Smith Shellnut Wilson first reported a position in Medpace in Q2 2024 and has held it in 9 quarters since.
  • Smith Shellnut Wilson's Medpace position peaked at $541K in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Smith Shellnut Wilson's 13F filing for Q2 2026, filed 3 Aug 2026.